Prospective Randomized Endovascular Therapy in Multiple Sclerosis - PREMiSE

Summary

Prospective Randomized Endovascular Therapy in Multiple Sclerosis - PREMiSE is a clinical trial^[1].

Key Facts

• Prospective Randomized Endovascular Therapy in Multiple Sclerosis - PREMiSE is in the country of United States^[2].
• Prospective Randomized Endovascular Therapy in Multiple Sclerosis - PREMiSE's instance of is recorded as clinical trial^[3].
• Prospective Randomized Endovascular Therapy in Multiple Sclerosis - PREMiSE's start time is recorded as +2010-06-30T00:00:00Z^[4].
• Prospective Randomized Endovascular Therapy in Multiple Sclerosis - PREMiSE's end time is recorded as +2011-12-31T00:00:00Z^[5].
• Prospective Randomized Endovascular Therapy in Multiple Sclerosis - PREMiSE's main subject is recorded as sclerosis^[6].
• Prospective Randomized Endovascular Therapy in Multiple Sclerosis - PREMiSE's main subject is recorded as multiple sclerosis^[7].
• Prospective Randomized Endovascular Therapy in Multiple Sclerosis - PREMiSE's number of participants is recorded as {'unit': '1', 'amount': '+20'}^[8].
• Prospective Randomized Endovascular Therapy in Multiple Sclerosis - PREMiSE's title is recorded as Prospective Randomized Endovascular Therapy in Multiple Sclerosis - PREMiSE^[9].
• Prospective Randomized Endovascular Therapy in Multiple Sclerosis - PREMiSE's short name is recorded as PREMiSE^[10].
• Prospective Randomized Endovascular Therapy in Multiple Sclerosis - PREMiSE's minimum age is recorded as {'unit': 'http://www.wikidata.org/entity/Q577', 'amount': '+18'}^[11].
• Prospective Randomized Endovascular Therapy in Multiple Sclerosis - PREMiSE's ClinicalTrials.gov ID is recorded as NCT01450072^[12].
• Prospective Randomized Endovascular Therapy in Multiple Sclerosis - PREMiSE's maximum age is recorded as {'unit': 'http://www.wikidata.org/entity/Q577', 'amount': '+65'}^[13].
• Prospective Randomized Endovascular Therapy in Multiple Sclerosis - PREMiSE's clinical trial phase is recorded as phase II clinical trial^[14].
• Prospective Randomized Endovascular Therapy in Multiple Sclerosis - PREMiSE's research site is recorded as University at Buffalo^[15].
• Prospective Randomized Endovascular Therapy in Multiple Sclerosis - PREMiSE's research subject recruitment status is recorded as completed^[16].
• Prospective Randomized Endovascular Therapy in Multiple Sclerosis - PREMiSE's study type is recorded as interventional study^[17].